Review summary
Teaching objective: Primary care after radical cystoprostatectomy with an ileal conduit for urothelial bladder cancer, on the AUA/ASCO/SUO muscle-invasive bladder cancer guideline, the AUA/SUO non-muscle-invasive guideline, and the CMID urologic cancer monograph: how high-risk non-muscle-invasive disease that recurs after intravesical therapy and earlier pelvic radiation leads to early cystectomy, and how often the final pathology is upstaged; why pT2a N0 disease needs no adjuvant therapy; surveillance by cross-sectional imaging every 6 to 12 months and upper-tract and kidney function checks every 6 months; the metabolic effects of an ileal conduit (hyperchloremic acidosis, kidney function, vitamin B12); stoma and peristomal skin care; and the difference between expected bacteriuria in conduit urine and a true kidney infection, with a culture taken by catheter from the stoma. His documented history of bladder growths, intravesical thiotepa with X-ray therapy, and a radical cystectomy with a small-intestine conduit frames the episode.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| 27 May 1911 | Born in Wallace, South Dakota. | CLM-0001 |
| 1949 | Begins service in the U.S. Senate. | CLM-0002 |
| 1967 | Seeks medical advice for blood in the urine; not treated. | CLM-0003 |
| 1968 | Several small benign bladder growths found and removed. | CLM-0003 |
| 1973 | Possibly cancerous bladder tissue treated with thiotepa and five weeks of X-ray therapy. | CLM-0004 |
| October 1976 | Radical cystectomy with removal of the prostate and a small-intestine urinary conduit at Memorial Sloan-Kettering Cancer Center. | CLM-0005 |
| January 5, 1977 | Resumes his Senate duties. | CLM-0006 |
| August 1977 | Inoperable pelvic recurrence found at an operation for bowel obstruction. | CLM-0007 |
| 13 January 1978 | Died in Waverly, Minnesota. | CLM-0008 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Hubert Horatio Humphrey Jr. was born on 27 May 1911 in Wallace, South Dakota. | confirmed | Humphrey, Hubert Horatio, Jr. Scribner Encyclopedia of American Lives, Thematic Series: The 1960s supports |
| D | Humphrey served in the U.S. Senate from Minnesota from 1949 to 1964, as vice president from 1965 to 1969, and again in the Senate from 1971 until his death. | confirmed | Hubert H. Humphrey: A Featured Biography supports |
| D | Humphrey sought medical advice in 1967 for blood in his urine; some doctors suspected bladder cancer, others disagreed, and he was not treated. In 1968 doctors found and removed several pinhead-size nonmalignant growths from his bladder. In 1994 researchers reported a p53 gene mutation in bladder cells from a 1967 urine sample of his. Hematuria with benign bladder growths years before the diagnosis of cancer; the 1994 report is a retrospective molecular study. |
confirmed | Scientists find genetic flaw that killed Hubert Humphrey (Associated Press) supports Medicine: H.H.H.'s Cystectomy supports Hruban RH, van der Riet P, Erozan YS, Sidransky D. Brief report: molecular biology and the early detection of carcinoma of the bladder: the case of Hubert H. Humphrey. N Engl J Med 1994;330(18):1276-8 context |
| D | In 1973 doctors found possibly cancerous tissue in his bladder and treated it with thiotepa and X-ray therapy, given five minutes a day for five weeks. Intravesical chemotherapy and pelvic radiation for suspected early bladder cancer. |
confirmed | Medicine: H.H.H.'s Cystectomy supports |
| D | After three years free of cancer, an examination at the National Naval Medical Center in Bethesda for symptoms of a urinary tract infection found a low-grade malignancy, and in October 1976 a six-hour radical cystectomy at Memorial Sloan-Kettering Cancer Center removed his bladder, prostate, lymph nodes, the fatty tissue around the bladder, and part of the urethra; the ureters were joined to a conduit made from a segment of small intestine, brought out to an opening on the skin to the right of the navel and drained into a bag. The nodes were to be examined for spread, and an experimental two-drug chemotherapy might be offered. Radical cystoprostatectomy with an ileal conduit urinary diversion. The nodal result and any treatment after the operation were not reported in the fetched sources. |
confirmed | Medicine: H.H.H.'s Cystectomy supports Milestones, Aug. 29, 1977 supports |
| D | He resumed his Senate duties in January 1977, serving as deputy president pro tempore from January 5, 1977. Used only to place his return to full-time work. |
confirmed | Hubert Humphrey supports |
| D | In August 1977 doctors found a malignant tumor on his pelvic bone during a four-hour operation in Minneapolis to relieve a bowel obstruction; the cancer was described as inoperable and terminal, and chemotherapy was planned. He returned to the Senate eleven weeks later, with further chemotherapy scheduled. Pelvic recurrence ten months after cystectomy. It falls after the synthetic episode and is used only as history. |
confirmed | Milestones, Aug. 29, 1977 supports The Nation: The Indomitable Senator Returns supports |
| D | Humphrey died on 13 January 1978 in Waverly, Minnesota. Recorded as a fact; no detail of his last months is used. |
confirmed | Humphrey, Hubert Horatio, Jr. Scribner Encyclopedia of American Lives, Thematic Series: The 1960s supports Hubert H. Humphrey: A Featured Biography supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Urothelial carcinoma of the bladder, multifocal, with carcinoma in situ, pT2a pN0 (0 of 18 nodes), margins negative, treated by radical cystoprostatectomy with an ileal conduit; no evidence of disease; under surveillance; synthetic modern detail linked to his documented bladder cancer | active | confirmed | both_with_link | CLM-0003, CLM-0004, CLM-0005 |
| S | Ileal conduit urostomy, right lower abdomen | active | confirmed | active | CLM-0005 |
| S | Acquired absence of the bladder and part of the urethra after radical cystectomy | active | confirmed | active | CLM-0005 |
| S | Acquired absence of the prostate after cystoprostatectomy | active | confirmed | active | CLM-0005 |
| S | Personal history of pelvic radiation for bladder tumor, with earlier intravesical thiotepa | active | confirmed | active | CLM-0004 |
| S | Hyperchloremic metabolic acidosis from the ileal conduit, mild | active | confirmed | active | CLM-0003, CLM-0004, CLM-0005 |
| S | Acute right pyelonephritis with an ileal conduit (Escherichia coli), with mild acute kidney injury, treated with oral ciprofloxacin and resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1977-01-06 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1977-01-06 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1977-01-06 | Chloride [Moles/volume] in Serum or Plasma | 106 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1977-01-06 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 22 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1977-01-06 | Urea nitrogen [Mass/volume] in Serum or Plasma | 18 mg/dL Reference 8-23 mg/dL |
http://loinc.org · 3094-0 |
| S | 1977-01-06 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1977-01-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1972)/1.73 sq M | 73 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1977-01-06 | Calcium [Mass/volume] in Serum or Plasma | 9.2 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 1977-01-06 | Albumin [Mass/volume] in Serum or Plasma | 3.7 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1977-01-06 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 88 U/L Reference 40-129 U/L |
http://loinc.org · 6768-6 |
| S | 1977-01-06 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1977-01-06 | Hemoglobin [Mass/volume] in Blood | 12.6 g/dL (low) Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 1977-01-06 | Leukocytes [#/volume] in Blood by Automated count | 6.4 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1977-01-06 | Platelets [#/volume] in Blood by Automated count | 284 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1977-01-06 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 412 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 1977-01-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1977-02-03 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1977-04-07 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1977-04-07 | Potassium [Moles/volume] in Serum or Plasma | 4.2 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1977-04-07 | Chloride [Moles/volume] in Serum or Plasma | 110 mmol/L (high) Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1977-04-07 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20 mmol/L (low) Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1977-04-07 | Urea nitrogen [Mass/volume] in Serum or Plasma | 16 mg/dL Reference 8-23 mg/dL |
http://loinc.org · 3094-0 |
| S | 1977-04-07 | Creatinine [Mass/volume] in Serum or Plasma | 1.15 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1977-04-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1972)/1.73 sq M | 71 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1977-04-07 | Hemoglobin [Mass/volume] in Blood | 13.4 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 1977-04-07 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 1977-07-07 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1977-07-07 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1977-07-07 | Chloride [Moles/volume] in Serum or Plasma | 106 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1977-07-07 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1977-07-07 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 mg/dL Reference 8-23 mg/dL |
http://loinc.org · 3094-0 |
| S | 1977-07-07 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1977-07-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1972)/1.73 sq M | 74 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1977-07-07 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1977-03-17 | Leukocytes [#/volume] in Blood by Automated count | 12.6 10*3/uL (high) Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1977-03-17 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1977-03-17 | Potassium [Moles/volume] in Serum or Plasma | 4.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1977-03-17 | Chloride [Moles/volume] in Serum or Plasma | 107 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1977-03-17 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20 mmol/L (low) Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1977-03-17 | Urea nitrogen [Mass/volume] in Serum or Plasma | 26 mg/dL (high) Reference 8-23 mg/dL |
http://loinc.org · 3094-0 |
| S | 1977-03-17 | Creatinine [Mass/volume] in Serum or Plasma | 1.41 mg/dL (high) Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1977-03-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1972)/1.73 sq M | 55 mL/min/1.73 m² (low) Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1977-03-17 | Leukocytes [#/area] in Urine sediment by Microscopy high power field | 55 /[HPF] (high) Reference <=5 /[HPF] |
http://loinc.org · 5821-4 |
| S | 1977-03-17 | Colony count [#/volume] in Urine | 100000 {CFU}/mL (high) Reference In a catheterized conduit specimen, 10,000 CFU/mL or more of one organism with symptoms supports infection |
http://loinc.org · 19090-0 |
| S | 1977-06-02 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1977-06-02 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
| S | 1977-06-02 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 1977-06-02 | Cholesterol [Mass/volume] in Serum or Plasma | 196 mg/dL Reference <=200 mg/dL |
http://loinc.org · 2093-3 |
| S | 1977-06-02 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 1977-06-02 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 124 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 1977-06-02 | Triglyceride [Mass/volume] in Serum or Plasma | 130 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1977-01-06 | Body height | 180 cm | 8302-2 | S |
| 1977-01-06 | Body weight | 76.5 kg | 29463-7 | S |
| 1977-01-06 | Body mass index (BMI) [Ratio] | 23.6 kg/m2 | 39156-5 | S |
| 1977-01-06 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1977-01-06 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1977-01-06 | Heart rate | 74 /min | 8867-4 | S |
| 1977-01-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 1977-01-06 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1977-01-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1977-02-03 | Body height | 180 cm | 8302-2 | S |
| 1977-02-03 | Body weight | 77.2 kg | 29463-7 | S |
| 1977-02-03 | Body mass index (BMI) [Ratio] | 23.8 kg/m2 | 39156-5 | S |
| 1977-02-03 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1977-02-03 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1977-02-03 | Heart rate | 72 /min | 8867-4 | S |
| 1977-02-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 1977-02-03 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1977-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1977-04-07 | Body height | 180 cm | 8302-2 | S |
| 1977-04-07 | Body weight | 77.6 kg | 29463-7 | S |
| 1977-04-07 | Body mass index (BMI) [Ratio] | 24 kg/m2 | 39156-5 | S |
| 1977-04-07 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1977-04-07 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1977-04-07 | Heart rate | 70 /min | 8867-4 | S |
| 1977-04-07 | Respiratory rate | 14 /min | 9279-1 | S |
| 1977-04-07 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1977-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1977-07-07 | Body height | 180 cm | 8302-2 | S |
| 1977-07-07 | Body weight | 78.8 kg | 29463-7 | S |
| 1977-07-07 | Body mass index (BMI) [Ratio] | 24.3 kg/m2 | 39156-5 | S |
| 1977-07-07 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1977-07-07 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1977-07-07 | Heart rate | 70 /min | 8867-4 | S |
| 1977-07-07 | Respiratory rate | 14 /min | 9279-1 | S |
| 1977-07-07 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1977-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1977-03-17 | Body height | 180 cm | 8302-2 | S |
| 1977-03-17 | Body weight | 76.9 kg | 29463-7 | S |
| 1977-03-17 | Body mass index (BMI) [Ratio] | 23.7 kg/m2 | 39156-5 | S |
| 1977-03-17 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1977-03-17 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 1977-03-17 | Heart rate | 98 /min | 8867-4 | S |
| 1977-03-17 | Respiratory rate | 18 /min | 9279-1 | S |
| 1977-03-17 | Body temperature | 38.4 Cel | 8310-5 | S |
| 1977-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 1977-06-02 | Body height | 180 cm | 8302-2 | S |
| 1977-06-02 | Body weight | 78.4 kg | 29463-7 | S |
| 1977-06-02 | Body mass index (BMI) [Ratio] | 24.2 kg/m2 | 39156-5 | S |
| 1977-06-02 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 1977-06-02 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1977-06-02 | Heart rate | 70 /min | 8867-4 | S |
| 1977-06-02 | Respiratory rate | 14 /min | 9279-1 | S |
| 1977-06-02 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1977-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: back at full-time work in a demanding public job with long days and frequent travel
- S Tobacco: no current use reported; past tobacco history is not recorded, because no reliable source was found
- S Lives with his spouse in his own home and an apartment near work; independent; drives
- S Supports: family, close friends, and a large circle of colleagues
Functional status
- S Independent in all activities of daily living, including emptying and changing his urostomy appliance
- S Walks 20 minutes a day, building up after surgery
Mental status
- S Alert, talkative, and optimistic; asks detailed questions about his results
- S Mood good; PHQ-9 minimal at the first visit
Allergies and medications
Allergies
- S No known allergy
Medications
- S Sodium bicarbonate 650 mg oral tablet, one tablet by mouth twice daily, for metabolic acidosis after an ileal conduit
- S Ciprofloxacin 500 mg oral tablet, one tablet by mouth twice daily for 7 days, for acute pyelonephritis
Procedures and immunizations
Procedures
- S Cystoscopy and transurethral resection of bladder tumors, at the cancer center: recurrent multifocal papillary urothelial carcinoma, low grade, with high-grade carcinoma in situ in random biopsies; muscularis propria present and not invaded (cTa with CIS); small, poorly compliant bladder after earlier radiation
- S Staging CT of the chest, abdomen, and pelvis with CT urography: thickened bladder wall; no hydronephrosis, upper-tract filling defect, enlarged lymph nodes, or distant disease
- S Radical cystoprostatectomy with bilateral pelvic lymph node dissection, partial urethrectomy, and ileal conduit urinary diversion, stoma in the right lower abdomen, at the cancer center. Pathology: multifocal urothelial carcinoma, high grade, with carcinoma in situ, invading the inner half of the muscularis propria (pT2a); 0 of 18 lymph nodes (pN0); ureteric and urethral margins negative; prostate with benign hyperplasia and no urothelial involvement
- S Renal ultrasound at six months: no hydronephrosis on either side; normal kidney size and cortical thickness; conduit decompressed
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 1976-11-18: High-dose influenza vaccine, this season
- S 1971-03-10: Tdap vaccine
- S 1977-06-02: Pneumococcal conjugate vaccine PCV20
- S 1977-06-02: Recombinant zoster vaccine, dose 1 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1967: Blood in the urine; bladder cancer suspected by some physicians but not treated (CLM-0003)
- D 1968: Several small benign bladder growths found and removed (CLM-0003)
- D 1973: Possibly cancerous bladder tissue treated with thiotepa and X-ray therapy, five minutes a day for five weeks (CLM-0004)
- D October 1976: Radical cystectomy with removal of the prostate, lymph nodes, and part of the urethra, and a urinary conduit made from small intestine, after a low-grade malignancy was found on examination for urinary infection symptoms (CLM-0005)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Leak-free urostomy appliance with healthy peristomal skin | 1977-04-07 | completed | Appliance refitted with a convex wafer at the consultation; no leaks in the two months after the refit and skin healed |
| Stable kidney function (creatinine within 0.3 mg/dL of the post-operative baseline) and bicarbonate 22 mmol/L or more | 1977-07-07 | completed | Creatinine 1.10 mg/dL; bicarbonate 24 mmol/L on sodium bicarbonate |
| Regain stamina after surgery: walk 30 minutes a day and regain weight | 1977-04-07 | completed | Walking 30 minutes most days; weight up 1.1 kg since the first visit |
| Written survivorship surveillance schedule in place, shared between urology and primary care | 1977-07-07 | completed | Schedule given; CT due at one year after surgery |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Urology consultation to share survivorship surveillance after radical cystectomy, review the stoma, and set the metabolic monitoring plan | completed | GL-AUA-MIBC-2024, GL-NCCN-BLADDER-2026 |
| Cancer surveillance after cystectomy for pT2a N0 disease: CT or MRI of the chest, abdomen, and pelvis every 6 to 12 months for 2 to 3 years, then yearly; no adjuvant therapy | completed | GL-AUA-MIBC-2024, GL-CMID-2026, GL-NCCN-BLADDER-2026 |
| Kidney and metabolic monitoring after an ileal conduit: chemistry with creatinine, chloride, and bicarbonate every 3 to 6 months in the first year, then yearly; upper-tract imaging every 6 months to year 3; vitamin B12 yearly; alkali for bicarbonate below 22 mmol/L | completed | GL-AUA-MIBC-2024, GL-CMID-2026 |
| Stoma care with the wound, ostomy, and continence nurse: appliance fitting, peristomal skin care, and parastomal hernia checks | completed | GL-AUA-MIBC-2024, GL-CMID-2026 |
| Urine infection plan with a conduit: no routine urine cultures or treatment of bacteriuria without symptoms; for fever, flank pain, or rigors, a culture taken by catheter from the stoma and prompt treatment; about 2 liters of fluid a day | completed | GL-AUA-MIBC-2024, GL-IDSA-CUTI-2025 |
| Distress screening at each visit, physical activity, and a written survivorship care plan | completed | GL-CMID-2026, GL-NCCN-BLADDER-2026 |
Planned encounters
- 1977-01-06 — First visit to establish shared care three months after radical cystoprostatectomy with an ileal conduit for bladder cancer (ENC-001)
- 1977-02-03 — Four-week follow-up with urology consultation: surveillance plan, stoma and peristomal skin, and metabolic monitoring (ENC-002)
- 1977-03-17 — Same-day sick visit for fever and right flank pain (ENC-005, unscheduled)
- 1977-04-07 — Six-month post-cystectomy follow-up: kidney function, acid-base, upper-tract ultrasound, and review after a kidney infection (ENC-003)
- 1977-06-02 — Subsequent annual wellness visit (ENC-006)
- 1977-07-07 — Nine-month post-cystectomy follow-up: acid-base on bicarbonate, stoma review, and the surveillance schedule (ENC-004)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Sick Visit
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Annual Wellness Visit, Subsequent
- Progress note 06 — Focused Visit (Care-plan review)
- Urology referral
- Urology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Sick Visit (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Annual Wellness Visit, Subsequent (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Urology referral (XML)
- Urology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Medicine: H.H.H.'s Cystectomy | TIME | other |
| SRC-0002 | Scientists find genetic flaw that killed Hubert Humphrey (Associated Press) | Deseret News | other |
| SRC-0003 | Hruban RH, van der Riet P, Erozan YS, Sidransky D. Brief report: molecular biology and the early detection of carcinoma of the bladder: the case of Hubert H. Humphrey. N Engl J Med 1994;330(18):1276-8 | New England Journal of Medicine (PubMed record) | scholarly |
| SRC-0004 | Milestones, Aug. 29, 1977 | TIME | other |
| SRC-0005 | The Nation: The Indomitable Senator Returns | TIME | other |
| SRC-0006 | Humphrey, Hubert Horatio, Jr. Scribner Encyclopedia of American Lives, Thematic Series: The 1960s | Encyclopedia.com | biography |
| SRC-0007 | Hubert H. Humphrey: A Featured Biography | United States Senate | government |
| SRC-0008 | Hubert Humphrey | Wikipedia | other |
| SRC-0009 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the pathway from recurrent high-risk non-muscle-invasive disease after radiation to early cystectomy, the omission of adjuvant therapy for pT2a N0, the surveillance intervals, and the infection management with a conduit. |
| provenance review | not_started | Historical facts from TIME (1976 and 1977), an Associated Press report (1994), the Senate biography, and a reference encyclopedia. No statement or health fact is attributed to a relative or to a named physician. Tobacco history is not recorded because no reliable source was found. |
| safe messaging review | not_started | The record is clinical and contains no political content; the later recurrence and death are recorded as history without detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.